| Astrazeneca Pharma India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506820 |
NSE Symbol : ASTRAZEN |
P/E(TTM) : 141.42 |
|
ISIN Demat : INE203A01020 |
Div & Yield% : 0.32 |
EPS(TTM) : 52.40 |
|
Book Value(₹) : 284.77 |
Market Cap(₹Cr) : 18,526.25 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 387.52 | 383.20 | 305.79 | 311.07 | 295.47 | 284.70 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 387.52 | 383.20 | 305.79 | 311.07 | 295.47 | 284.70 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 8.35 | 8.66 | 9.66 | 24.80 | 8.10 | 8.00 |
| Total Income | 395.87 | 391.86 | 315.45 | 335.87 | 303.57 | 292.70 |
| Total Expenditure | 407.01 | 333.81 | 290.73 | 258.31 | 228.23 | 265.08 |
| PBIDT | -11.14 | 58.05 | 24.72 | 77.56 | 75.34 | 27.62 |
| Interest | 0.11 | -0.07 | 0.61 | 0.50 | 0.15 | 0.09 |
| PBDT | -11.25 | 58.12 | 24.10 | 77.06 | 75.19 | 27.53 |
| Depreciation | 3.91 | 3.76 | 3.70 | 3.67 | 3.79 | 4.25 |
| Tax | 10.75 | 15.52 | 4.65 | 21.29 | 17.47 | 8.38 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -14.12 | -0.64 | -0.06 | -0.28 | 0.07 | -2.37 |
| Reported Profit After Tax | -11.79 | 39.48 | 15.80 | 52.37 | 53.86 | 17.27 |
| Extra-ordinary Items | -46.81 | 0.00 | 0.00 | 11.66 | 0.00 | -31.85 |
| Adjusted Profit After Extra-ordinary item | 35.02 | 39.48 | 15.80 | 40.71 | 53.86 | 49.12 |
| EPS (Unit Curr.) | -4.72 | 15.79 | 6.32 | 20.95 | 21.54 | 6.91 |
| EPS (Adj) (Unit Curr.) | -4.72 | 15.79 | 6.32 | 20.95 | 21.54 | 6.91 |
| Calculated EPS (Unit Curr.) | -4.72 | 15.79 | 6.32 | 20.95 | 21.54 | 6.91 |
| Calculated EPS (Adj) (Unit Curr.) | -4.72 | 15.79 | 6.32 | 20.95 | 21.54 | 6.91 |
| Calculated EPS (Ann.) (Unit Curr.) | -18.86 | 63.17 | 25.28 | 83.79 | 86.18 | 27.63 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -18.86 | 63.17 | 25.28 | 83.79 | 86.18 | 27.63 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -2.87 | 15.15 | 8.08 | 24.93 | 25.50 | 9.70 |
| PBDTM(%) | -2.90 | 15.17 | 7.88 | 24.77 | 25.45 | 9.67 |
| PATM(%) | -3.04 | 10.30 | 5.17 | 16.84 | 18.23 | 6.07 |